Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
Top Cited Papers
Open Access
- 1 August 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 65 (8) , 1102-1107
- https://doi.org/10.1001/archneur.65.8.1102
Abstract
Research from JAMA Neurology — Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer DiseaseKeywords
This publication has 17 references indexed in Scilit:
- Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive ImpairmentArchives of General Psychiatry, 2007
- Aspects of β-Amyloid as a Biomarker for Alzheimer's DiseaseBiomarkers in Medicine, 2007
- Detection of a Soluble Form of BACE-1 in Human Cerebrospinal Fluid by a Sensitive Activity AssayClinical Chemistry, 2006
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humansAnnals of Neurology, 2006
- Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient MiceJournal of Biological Chemistry, 2005
- Novel mutations introduced at the β-site of amyloid β protein precursor enhance the production of amyloid β peptide by BACE1 in vitro and in cellsJournal of Alzheimer's Disease, 2005
- Increased β‐Secretase activity in cerebrospinal fluid of Alzheimer's disease subjectsAnnals of Neurology, 2004
- CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy studyNeurology, 2003
- β-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer DiseaseArchives of Neurology, 2002
- Vascular dementiaNeurology, 1993